Award Recognitions Brainomix has recently been recognized with multiple prestigious awards in the healthtech sector, showcasing its innovative AI-powered imaging solutions. Leveraging these accolades can help open doors to new partnerships and clients seeking cutting-edge healthcare technologies.

US Expansion With the launch of its cutting-edge stroke AI platform and FDA clearances, Brainomix is strategically targeting the US market for expansion. This presents a significant sales opportunity for establishing partnerships with healthcare facilities and providers looking to enhance their stroke care capabilities.

Robotic Platform Development Brainomix's collaboration with Nanoflex Robotics to develop a robotic platform for remote treatments of stroke patients offers a unique sales opportunity. Business development professionals can explore partnerships with hospitals and telemedicine providers interested in advanced robotic solutions for patient care.

AI Integrated Diagnosis Platform The collaboration between Brainomix and Nanoflex Robotics to create an AI-powered integrated remote stroke diagnosis and treatment platform presents a lucrative sales opportunity. Sales development representatives can target healthcare institutions looking to streamline their stroke diagnosis and treatment processes using cutting-edge technology.

Financial Stability With a revenue range of $10M - $50M and recent funding of $490K, Brainomix showcases financial stability in the competitive healthtech market. This financial robustness positions the company as a reliable partner for long-term collaborations and product implementations across the medical sector.